(Q38556348)

4 September 2017

title

Biodegradable scleral implant for intravitreal controlled release of fluconazole (English)

1 reference

4 September 2017

0 references

Miyamoto H

1

1 reference

4 September 2017

Ogura Y

2

1 reference

4 September 2017

Hashizoe M

3

1 reference

4 September 2017

Kunou N

4

1 reference

4 September 2017

Honda Y

5

1 reference

4 September 2017

Ikada Y

6

1 reference

4 September 2017

publication date

1 September 1997

1 reference

4 September 2017

1 reference

4 September 2017

volume

16

1 reference

4 September 2017

issue

9

1 reference

4 September 2017

page(s)

930-935

1 reference

Feasibility of drug targeting to the retinal pigment epithelium with biodegradable microspheres

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

The place of elective vitrectomy in the management of patients with Candida endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Fluconazole in the management of fungal ocular infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Fluconazole, a new antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Ocular uptake of fluconazole following oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Ocular involvement in patients with fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Multivesicular liposomes. Sustained release of the antimetabolite cytarabine in the eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Intravitreal injection of liposome-encapsulated ganciclovir in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Intravitreal Sustained-Release Ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Pathology of cytomegalovirus retinitis treated with sustained release intravitreal ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Endogenous Candida endophthalmitis. Management without intravenous amphotericin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

Postpartum Candida endophthalmitis treated with fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.16.9.930.5042

10.1076/CEYR.16.9.930.5042

21 January 2018

Identifiers

DOI

1 reference

4 September 2017

1 reference